| 2015 |
Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. June 2015;75:229-239. |
18 |
11 |
| 2017 |
Whyte MP. Hypophosphatasia: an overview for 2017. Bone. September 2017;102:15-25. |
14 |
12 |
| 2020 |
Mumm S, Gottesman GS, Wenkert D, Campeau PM, Nenninger A, Huskey M, Bijanki VN, Veis DJ, Barnes AM, Marini JC, Stolina M, Zhang F, McAlister WH, Whyte MP. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation. Bone. January 2020;130:115047. |
2 |
0 |
| 2020 |
Whyte MP, Amalnath SD, McAlister WH, McKee MD, Veis DJ, Huskey M, Duan S, Bijanki VN, Alur S, Mumm S. Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: the first digenic SIBLING protein osteopathy? Bone. March 2020;132:115190. |
1 |
1 |
| 2020 |
Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. April 2020;133:115224. |
2 |
0 |
| 2020 |
Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. Bone. May 2020;134:115300. |
1 |
0 |
| 2020 |
Lin EL, Gottesman GS, McAlister WH, Bijanki VN, Mack KE, Griffin DM, Mumm S, Whyte MP. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health. Bone. July 2020;136:115322. |
0 |
0 |
| 2020 |
Whyte MP, Campeau PM, McAlister WH, Roodman GD, Kurihara N, Nenninger A, Duan S, Gottesman GS, Bijanki VN, Sedighi H, Veis DJ, Mumm S. Juvenile Paget's disease from heterozygous mutation of SP7 encoding osterix (specificity protein 7, transcription factor SP7). Bone. August 2020;137:115364. |
2 |
2 |
| 2020 |
Brance ML, Brun LR, Cóccaro NM, Aravena A, Duan S, Mumm S, Whyte MP. High bone mass from mutation of low-density lipoprotein receptor-related protein 6 (LRP6). Bone. December 2020;141:115550. |
0 |
0 |
| 2021 |
Seefried L, Kishnani PS, Moseley S, Denker AE, Watsky E, Whyte MP, Dahir KM. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Bone. January 2021;142:115664. |
1 |
0 |
| 2021 |
Whyte MP, Aronson J, McAlister WH, Weinstein RS, Wenkert D, Clements KL, Gottesman GS, Madson KL, Stolina M, Bijanki VN, Plotkin H, Huskey M, Duan S, Mumm S. Coalescing expansile skeletal disease: delineation of an extraordinary osteopathy involving the ifitm5 mutation of osteogenesis imperfecta type V. Bone. April 2021;145:115835. |
0 |
0 |
| 2021 |
Cook FJ, Seagrove-Guffey M, Mumm S, Veis DJ, McAlister WH, Bijanki VN, Wenkert D, Whyte MP. Non-endemic skeletal fluorosis: causes and associated secondary hyperparathyroidism (case report and literature review). Bone. April 2021;145:115839. |
1 |
0 |
| 2021 |
Whyte MP, May JD, McAlister WH, Burgener K, Cortez SR, Kreienkamp R, Castro O, Verzola R, Zavala AS, McPherson CC, Gottesman GS, Ericson KL, Coburn SP, Arbelaez AM. Vitamin B₆ deficiency with normal plasma levels of pyridoxal 5′-phosphate in perinatal hypophosphatasia. Bone. September 2021;150:116007. |
2 |
1 |
| 2022 |
Whyte MP, Zhang F, Wenkert D, Mack KE, Bijanki VN, Ericson KL, Coburn SP. Hypophosphatasia: vitamin B₆ status of affected children and adults. Bone. January 2022;154:116204. |
0 |
0 |
| 2022 |
Salles Rosa Neto N, Englert D, McAlister WH, Mumm S, Mills D, Veis DJ, Burshell A, Boyde A, Whyte MP. Periarticular calcifications containing giant pseudo-crystals of francolite in skeletal fluorosis from 1,1-difluoroethane “huffing”. Bone. July 2022;160:116421. |
0 |
0 |
| 2023 |
Whyte MP. Carbonic anhydrase II deficiency. Bone. April 2023;169:116684. |
1 |
1 |
| 2023 |
Craven M, Vajravelu ME, Shekdar KV, Levine MA, Mumm S, Whyte MP, Mancilla EE. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): clinical characterization and response to bisphosphonate therapy. Bone. May 2023;170:116698. |
0 |
0 |
| 2023 |
Whyte MP. Osteopetrosis: discovery and early history of “marble bone disease”. Bone. June 2023;171:116737. |
0 |
0 |
| 2023 |
Whyte MP, McAlister WH, Dhiman V, Gopinathan NR, Bhadada SK. Drug-induced osteopetrosis. Bone. August 2023;173:116788. |
0 |
0 |
| 2023 |
Teti A, Whyte MP. Osteopetrosis: gene-based nosology and significance. Bone. October 2023;175:116854. |
0 |
0 |
| 2016 |
Millán JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif Tiss Int. April 2016;98(4):398-416. |
23 |
15 |
| 2021 |
Padidela R, Whyte MP, Glorieux FH, Munns CF, Ward LM, Nilsson O, Portale AA, Simmons JH, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Williams A, Nixon A, Sun W, Chen A, Skrinar A, Imel EA. Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with x-linked hypophosphatemia. Calcif Tiss Int. May 2021;108(5):622-633. |
0 |
0 |
| 2010 |
Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MCH, Weinstein RS, Whyte M. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. November 2010;25(11):2267-2294. |
62 |
45 |
| 2014 |
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MCH, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. January 2014;29(1):1-23. |
59 |
43 |
| 2020 |
Smith PS, Gottesman GS, Zhang F, Cook F, Ramirez B, Wenkert D, Wollberg V, Huskey M, Mumm S, Whyte MP. X‐linked hypophosphatemia: uniquely mild disease associated with PHEX 3′‐UTR mutation c.*231A>G (a retrospective case–control study). J Bone Miner Res. May 2020;35(5):920-931. |
4 |
2 |
| 2020 |
di Carlo FS, Pazzaglia L, Mumm S, Benassi MS, De Chiara A, Franchi A, Parafioriti A, Righi A, Esposito T, Whyte MP, Gianfrancesco F. ZNF687 mutations in an extended cohort of neoplastic transformations in Paget's disease of bone: implications for clinical pathology. J Bone Miner Res. October 2020;35(10):1974-1980. |
0 |
0 |
| 2021 |
Whyte MP. Tumor‐induced osteomalacia: treatment progress using burosumab, an anti‐FGF23 monoclonal antibody. J Bone Miner Res. April 2021;36(4):625-626. |
0 |
0 |
| 2016 |
Whyte MP. Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. April 2016;12(4):233-246. |
23 |
17 |